Zoetis, Inc. (New York Stock Exchange:ZTS)

About the company

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. The company operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.


Health Technology


Pharmaceuticals: Generic




Kristin C. Peck


New York Stock Exchange




Total Revenue




Market Capitalization


Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin


Operating Margin (in %)

Total operating margin


Net Margin (in %)

Total net margin


Dividend Yield (in %)

Dividend per share


Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Zoetis, Inc. ZTS 66589.64 6339.00 23.87 41.45 25.41
Mylan NV MYL 8551.18 11624.00 0.76 137.83 0.54
BridgeBio Pharma, Inc. BBIO 3680.82 41.00 9.69 -12.68 -718.08
Taro Pharmaceutical Industries Ltd. TARO 2544.10 645.00 1.22 10.54 37.88
TherapeuticsMD, Inc. TXMD 388.62 58.00 -9.00 -1.99 -333.88
Abeona Therapeutics, Inc. ABEO 210.80 3.00 2.15 -2.07 75.95
LifeVantage Corp. LFVN 195.45 230.00 6.55 16.49 5.06
Kindred Biosciences, Inc. KIN 150.93 4.00 2.51 -2.21 None
Cocrystal Pharma, Inc. COCP 53.55 2.00 1.96 -0.92 -733.84
China Pharma Holdings, Inc. CPHI 25.04 10.00 2.99 -1.16 -214.63
Jaguar Health, Inc. JAGX 4.86 5.00 3.60 0.07 -887.14

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Were Hedge Funds Right About Zoetis Inc (ZTS)?

5h ago, source: YAHOO!

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of ...

Trianni and Zoetis Announce Agreement to Develop a Transgenic Antibody Discovery Platform for Use in Animal Health

1d ago, source: YAHOO!

Trianni, Inc. (TRIANNI) and Zoetis (NYSE: ZTS) today announced a collaboration for the development of transgenic monoclonal antibody platforms for the discovery of new veterinary treatments.

Zoetis to Host Webcast and Conference Call on Second Quarter 2020 Financial Results

12d ago, source: Business Wire

(NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 6, 2020. Chief Executive Officer ...

Trianni, Zoetis to collaborate on veterinary product development

1d ago, source: Feed Stuffs

Collaboration will enhance Zoetis's pipeline of novel monoclonal antibodies and hasten development of therapeutics for a range of animal diseases.

Fulton Bank N. A. Increases Stock Position in Zoetis Inc (NYSE:ZTS)

2d ago, source: theenterpriseleader.com

Fulton Bank N. A. raised its position in shares of Zoetis Inc (NYSE:ZTS) by 148.3% in the 2nd quarter, according to its most ...

Engineers Gate Manager LP Increases Stake in Zoetis Inc (NYSE:ZTS)

11d ago, source: modernreaders.com

Engineers Gate Manager LP boosted its stake in shares of Zoetis Inc (NYSE:ZTS) by 27.8% in the 1st quarter, according to the ...

Toni Bothwell 2020 Recipient of the Canadian Animal Health Institute Recognizing Its Leaders Award

2d ago, source: Business Insider

The Canadian Animal Health Institute (CAHI) is pleased to announce that Toni Bothwell, Director, Regulatory Affairs & Pharmacovigilance at Zoetis Canada is the 2020 recipient of its internal ...

Portfolio items

Follow companies to create your optimal portfolio.
Refresh this page to see your newly added stocks.